1.Medtronic
MDT (NYSE)
Medtronic stands out as a top-rated Dividend Aristocrat for 2026, recognized for its impressive history of dividend growth, making it an attractive option for investors seeking reliable income. Although the stock has faced a challenging year with a -9.01% return and a -35.74% decline over the last five years, it currently offers a solid dividend yield of 3.52%. Analysts are optimistic, with a median 12-month price target of $91.00, reflecting strong confidence in this financially healthy company.
Pros:
- Strong dividend growth history
- Market leader in medical technology
Cons:
- Recent negative returns
- Market volatility risk
2.Nordson Corporation
NDSN (NASDAQ)
Nordson Corporation stands out as a U.S.-listed Dividend Aristocrat, recognized by Yahoo Finance among the top three picks for 2026. With a modest dividend yield of 1.11% and impressive one-year and five-year returns of 35.86% and 34.62%, respectively, it presents a compelling option for investors seeking reliable income from financially healthy companies. Analysts are optimistic, setting a median 12-month price target of $325, with ratings that include an Outperform from Oppenheimer and a Buy from DA Davidson.
Pros:
- Strong recent performance
- Diverse product offerings
Cons:
- Market volatility risk
- Dependence on industrial sector
3.Lowe’s Companies
LOW (NYSE)
Lowe’s Companies stands out as a U.S.-listed Dividend Aristocrat, making it a compelling choice for investors looking for reliable income in 2026. With a current dividend yield of approximately 2.37%, it has delivered a 5-year return of 9.55%, despite a recent 1-year decline of 7.82%. Analysts maintain a favorable outlook, with a median 12-month price target of $265.00, reflecting confidence in its financial health and consistent payouts.
Pros:
- Strong brand recognition
- Consistent dividend payments
Cons:
- Recent stock price decline
- Market competition
4.Clorox
CLX (NYSE)
Clorox, a top-rated Dividend Aristocrat featured among Morningstar's best picks for 2026, boasts a solid dividend yield of 5.12%. Despite recent challenges reflected in a 1-year return of -23.96% and a 5-year return of -47.08%, analysts maintain a median price target of $97.50, indicating potential upside. Investors can take comfort in the company's strong dividend profile and the belief that it will deliver excess returns over the long term.
Pros:
- Established dividend profile
- Strong brand recognition
Cons:
- Recent negative returns
- Market volatility risk
5.Abbott Laboratories
ABT (NYSE)
Abbott Laboratories, a well-established Dividend Aristocrat, boasts an impressive 54 consecutive years of dividend growth, making it a reliable choice for defensive healthcare exposure in the U.S. market. With a current dividend yield of approximately 2.78%, the stock has faced challenges recently, reflected in a 1-year return of -17.45% and a 5-year return of -12.95%. Analysts maintain a cautious outlook, with a median 12-month price target of $120.00, indicating potential upside from the current levels.
Pros:
- Long history of dividend growth
- Diverse healthcare portfolio
Cons:
- Recent negative returns
- Market competition
Did you know?
Dividend Aristocrats are S&P 500 companies that have raised dividends for at least 25 consecutive years. This list focuses on that quality bar: compare current yield, sector mix, and valuation versus the broader market.
Final Words
As you consider the best dividend aristocrats this August 2026, remember to evaluate each option based on your investment goals and risk tolerance. Take time to compare these opportunities and conduct your own research to make informed decisions that align with your financial strategy.
Frequently Asked Questions
Medtronic is highlighted as a strong Dividend Aristocrat due to its long dividend-growth record, showcasing its stability and commitment to returning value to shareholders. With a dividend yield of approximately 3.52%, it attracts investors looking for reliable income.
Medtronic's next dividend is $0.72, distributed quarterly. This consistent payment reflects the company's ongoing commitment to its shareholders despite fluctuations in market performance.
Medtronic's stock has shown a 3-month return of 0.92%, but a year-to-date return of -12.89%, indicating some volatility. Investors should consider these trends while evaluating the company's performance.
Investing in dividend aristocrats carries risks such as market volatility and sector-specific challenges that can affect stock performance. It's essential to assess the company's fundamentals and market conditions before investing.
To choose the best dividend aristocrat, consider factors such as dividend yield, dividend growth history, overall financial health, and market conditions. Comparing these metrics across different companies can help you make a more informed decision.
Medtronic has a market cap of $107.11 billion, indicating its size and stability within the healthcare sector. A larger market cap often suggests a company is more established and may be less volatile compared to smaller companies.
